Prescribing Information Important Safety Information
About CSID

Why Did It Take so Long to Be Diagnosed with CSID?

Congenital Sucrase-Isomaltase Deficiency (CSID) is a rare disorder, sometimes called an orphan disease or disorder. According to the National Institutes of Health, a disease that affects fewer than 200,000 people is considered a rare disease in the United States. Using this criterion, there are approximately 7,000 recognized rare diseases in the country. Of the 7,000 recognized rare disorders, only 200 have an FDA-approved medical treatment.

Getting a correct diagnosis is often a major challenge for someone who has a rare disorder. Many individuals are unable to get a diagnosis, are misdiagnosed, or receive several different diagnoses over time. There are many reasons why getting a rare disease diagnosis can be a long, frustrating experience.

First, it may seem obvious, but the very fact that a disease is rare makes it difficult to be recognized. Detailed information regarding CSID may not be included in the standard training a physician receives. A physician may have read some information about CSID in medical school, if at all. Most pediatric gastroenterologists have not seen a child with CSID in their practice.

Overall, physicians receive little medical training in rare disorders and can spend an entire career without ever encountering one. There may also be a delay in diagnosis since the symptoms of CSID (diarrhea, bloating, and abdominal pain) are shared by other more common gastrointestinal diseases.

Also compounding the diagnostic process is the fact that the historically definitive assay for diagnosing CSID, the disaccharidase assay, analyzes sucrase activity in small bowel biopsies obtained during an upper gastrointestinal endoscopy examination. Many pediatric gastroenterologists are reluctant to subject an infant or small child to such an invasive procedure. Also, many gastroenterologists do not order the disaccharidase analysis test when small bowel biopsies are conducted.

It is important to maintain a mindset focused on moving forward once you or your child has been diagnosed with CSID. Yes, it may have taken a long time to reach a proper diagnosis. If possible, try to take that frustration and put it to good use by educating yourself about CSID and how best to adapt to life with CSID.

Take Back Control of Your Life

©2025, All Rights Reserved. Presented by QOL Medical, LLC. Do Not Sell/Share My Personal Information
View Important Safety Information

IMPORTANT SAFETY INFORMATION:

Collapse Important Safety Information
Expand Important Safety Information

Important Safety Information for Sucraid® (sacrosidase) Oral Solution

  • Tell your doctor if you are allergic to, have ever had a reaction to, or have ever had difficulty taking yeast, yeast products, papain, or glycerin (glycerol).
  • Sucraid® may cause a serious allergic reaction. If you notice any swelling or have difficulty breathing, get emergency help right away.
  • Sucraid® does not break down some sugars that come from the digestion of starch. You may need to restrict the amount of starch in your diet. Your doctor will tell you if you should restrict starch in your diet.
  • Tell your doctor if you have diabetes, as your blood glucose levels may change if you begin taking Sucraid®. Your doctor will tell you if your diet or diabetes medicines need to be changed.
  • Some patients treated with Sucraid® may have worse abdominal pain, vomiting, nausea, or diarrhea. Constipation, difficulty sleeping, headache, nervousness, and dehydration have also occurred in patients treated with Sucraid®. Check with your doctor if you notice these or other side effects.
  • Sucraid® has not been tested to see if it works in patients with secondary (acquired) sucrase deficiency.
  • NEVER HEAT SUCRAID® OR PUT IT IN WARM OR HOT BEVERAGES OR INFANT FORMULA. Do not mix Sucraid® with fruit juice or take it with fruit juice. Take Sucraid® as prescribed by your doctor. Normally, half of the dose of Sucraid® is taken just before a meal or snack and the other half is taken during the meal or snack.
  • Sucraid® should be refrigerated at 36°F-46°F (2°C-8°C) and should be protected from heat and light; single-use containers can be removed from refrigeration and stored at 59°F-77°F (15°C-25°C) for up to 3 days (72 hours). Refer to Instructions for Use for full information on how to take Sucraid®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Indication

Sucraid® (sacrosidase) Oral Solution is indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older.